Rating History for BridgeBio Pharma (BBIO) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/28/2026 | Eliana Merle | New Coverage | Overweight (N/A) |
157.00 (N/A) |
77.81 (65.36) |
-16% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/28/2026 | Eliana Merle | New Coverage | Overweight (N/A) |
157.00 (N/A) |
77.81 (65.36) |
-16% | Details |